According to Latest Study , the global market for Chimeric Antigen Receptor (CAR)-T Cell Therapy should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Chimeric Antigen Receptor (CAR)-T Cell Therapy market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Chimeric Antigen Receptor (CAR)-T Cell Therapy market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Abecma segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Chimeric Antigen Receptor (CAR)-T Cell Therapy include Autolus Therapeutics, CARsgen Therapeutics, Juno Therapeutics, Sorrento Therapeutics, bluebird bio, CELGENE CORPORATION, Eureka Therapeutics, Avacta Life Sciences and Calyxt, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Chimeric Antigen Receptor (CAR)-T Cell Therapy. Report Highlights:

(1) Global Chimeric Antigen Receptor (CAR)-T Cell Therapy market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Chimeric Antigen Receptor (CAR)-T Cell Therapy market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Chimeric Antigen Receptor (CAR)-T Cell Therapy market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Chimeric Antigen Receptor (CAR)-T Cell Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Chimeric Antigen Receptor (CAR)-T Cell Therapy segment by type and by application and regional segment by type and by application.

(6) Chimeric Antigen Receptor (CAR)-T Cell Therapy industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Abecma

Breyanzi

Kymriah

Tecartus

Yescarta

Others

Market segment by application, can be divided into

Hospital

Diagnostic Center

Other

Market segment by players, this report covers

Autolus Therapeutics

CARsgen Therapeutics

Juno Therapeutics

Sorrento Therapeutics

bluebird bio

CELGENE CORPORATION

Eureka Therapeutics

Avacta Life Sciences

Calyxt

Celyad Oncology SA

Fortress Biotech

IMMUNE THERAPEUTICS

Gilead Sciences

Novartis AG

Alaunos Therapeutics

Poseida Therapeutics

1 Market Overview

1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR)-T Cell Therapy

1.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size and Forecast

1.3 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Share in Global Market, 2019-2030

1.4.2 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size: China VS Global, 2019-2030

1.5 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Dynamics

1.5.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Drivers

1.5.2 Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints

1.5.3 Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Trends

1.5.4 Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Policy

2 Global Competitive Situation by Company

2.1 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024)

2.2 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Concentration Ratio

2.4 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Mergers & Acquisitions, Expansion Plans

2.5 Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024)

3.2 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Chimeric Antigen Receptor (CAR)-T Cell Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Chimeric Antigen Receptor (CAR)-T Cell Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Chain

4.2 Chimeric Antigen Receptor (CAR)-T Cell Therapy Upstream Analysis

4.3 Chimeric Antigen Receptor (CAR)-T Cell Therapy Midstream Analysis

4.4 Chimeric Antigen Receptor (CAR)-T Cell Therapy Downstream Analysis

5 Sights by Type

5.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Classification

5.1.1 Abecma

5.1.2 Breyanzi

5.1.3 Kymriah

5.1.4 Tecartus

5.1.5 Yescarta

5.1.6 Others

5.2 By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & CAGR, 2019 VS 2023 VS 2030

5.3 By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030

6 Sights by Application

6.1 Chimeric Antigen Receptor (CAR)-T Cell Therapy Segment by Application

6.1.1 Hospital

6.1.2 Diagnostic Center

6.1.3 Other

6.2 By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019 VS 2023 VS 2030

7.2 By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

7.3 North America

7.3.1 North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Market Share

7.4 Europe

7.4.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Market Share

7.6 South America

7.6.1 South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & CAGR，2019 VS 2023 VS 2030

8.2 By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.3.2 By Company, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.4.2 By Company, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.5.2 By Company, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.5.3 By Type, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.6.2 By Company, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.7.2 By Company, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.9.2 By Company, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.9.3 By Type, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Autolus Therapeutics

9.1.1 Autolus Therapeutics Company Information, Head Office, Market Area and Industry Position

9.1.2 Autolus Therapeutics Company Profile and Main Business

9.1.3 Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.1.4 Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.1.5 Autolus Therapeutics Recent Developments

9.2 CARsgen Therapeutics

9.2.1 CARsgen Therapeutics Company Information, Head Office, Market Area and Industry Position

9.2.2 CARsgen Therapeutics Company Profile and Main Business

9.2.3 CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.2.4 CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.2.5 CARsgen Therapeutics Recent Developments

9.3 Juno Therapeutics

9.3.1 Juno Therapeutics Company Information, Head Office, Market Area and Industry Position

9.3.2 Juno Therapeutics Company Profile and Main Business

9.3.3 Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.3.4 Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.3.5 Juno Therapeutics Recent Developments

9.4 Sorrento Therapeutics

9.4.1 Sorrento Therapeutics Company Information, Head Office, Market Area and Industry Position

9.4.2 Sorrento Therapeutics Company Profile and Main Business

9.4.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.4.4 Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.4.5 Sorrento Therapeutics Recent Developments

9.5 bluebird bio

9.5.1 bluebird bio Company Information, Head Office, Market Area and Industry Position

9.5.2 bluebird bio Company Profile and Main Business

9.5.3 bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.5.4 bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.5.5 bluebird bio Recent Developments

9.6 CELGENE CORPORATION

9.6.1 CELGENE CORPORATION Company Information, Head Office, Market Area and Industry Position

9.6.2 CELGENE CORPORATION Company Profile and Main Business

9.6.3 CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.6.4 CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.6.5 CELGENE CORPORATION Recent Developments

9.7 Eureka Therapeutics

9.7.1 Eureka Therapeutics Company Information, Head Office, Market Area and Industry Position

9.7.2 Eureka Therapeutics Company Profile and Main Business

9.7.3 Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.7.4 Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.7.5 Eureka Therapeutics Recent Developments

9.8 Avacta Life Sciences

9.8.1 Avacta Life Sciences Company Information, Head Office, Market Area and Industry Position

9.8.2 Avacta Life Sciences Company Profile and Main Business

9.8.3 Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.8.4 Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.8.5 Avacta Life Sciences Recent Developments

9.9 Calyxt

9.9.1 Calyxt Company Information, Head Office, Market Area and Industry Position

9.9.2 Calyxt Company Profile and Main Business

9.9.3 Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.9.4 Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.9.5 Calyxt Recent Developments

9.10 Celyad Oncology SA

9.10.1 Celyad Oncology SA Company Information, Head Office, Market Area and Industry Position

9.10.2 Celyad Oncology SA Company Profile and Main Business

9.10.3 Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.10.4 Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.10.5 Celyad Oncology SA Recent Developments

9.11 Fortress Biotech

9.11.1 Fortress Biotech Company Information, Head Office, Market Area and Industry Position

9.11.2 Fortress Biotech Company Profile and Main Business

9.11.3 Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.11.4 Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.11.5 Fortress Biotech Recent Developments

9.12 IMMUNE THERAPEUTICS

9.12.1 IMMUNE THERAPEUTICS Company Information, Head Office, Market Area and Industry Position

9.12.2 IMMUNE THERAPEUTICS Company Profile and Main Business

9.12.3 IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.12.4 IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.12.5 IMMUNE THERAPEUTICS Recent Developments

9.13 Gilead Sciences

9.13.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position

9.13.2 Gilead Sciences Company Profile and Main Business

9.13.3 Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.13.4 Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.13.5 Gilead Sciences Recent Developments

9.14 Novartis AG

9.14.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.14.2 Novartis AG Company Profile and Main Business

9.14.3 Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.14.4 Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.14.5 Novartis AG Recent Developments

9.15 Alaunos Therapeutics

9.15.1 Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position

9.15.2 Alaunos Therapeutics Company Profile and Main Business

9.15.3 Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.15.4 Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.15.5 Alaunos Therapeutics Recent Developments

9.16 Poseida Therapeutics

9.16.1 Poseida Therapeutics Company Information, Head Office, Market Area and Industry Position

9.16.2 Poseida Therapeutics Company Profile and Main Business

9.16.3 Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

9.16.4 Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

9.16.5 Poseida Therapeutics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Restraints

Table 3. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Trends

Table 4. Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Policy

Table 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Company (2019-2024)

Table 7. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Manufacturers Product Type

Table 10. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue by Company (2019-2024) & (US$ million)

Table 11. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Chimeric Antigen Receptor (CAR)-T Cell Therapy Upstream (Raw Materials)

Table 13. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Typical Customers

Table 14. Chimeric Antigen Receptor (CAR)-T Cell Therapy Typical Distributors

Table 15. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Table 22. Autolus Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 23. Autolus Therapeutics Company Profile and Main Business

Table 24. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 25. Autolus Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 26. Autolus Therapeutics Recent Developments

Table 27. CARsgen Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 28. CARsgen Therapeutics Company Profile and Main Business

Table 29. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 30. CARsgen Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 31. CARsgen Therapeutics Recent Developments

Table 32. Juno Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 33. Juno Therapeutics Company Profile and Main Business

Table 34. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 35. Juno Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 36. Juno Therapeutics Recent Developments

Table 37. Sorrento Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 38. Sorrento Therapeutics Company Profile and Main Business

Table 39. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 40. Sorrento Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 41. Sorrento Therapeutics Recent Developments

Table 42. bluebird bio Company Information, Head Office, Market Area and Industry Position

Table 43. bluebird bio Company Profile and Main Business

Table 44. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 45. bluebird bio Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 46. bluebird bio Recent Developments

Table 47. CELGENE CORPORATION Company Information, Head Office, Market Area and Industry Position

Table 48. CELGENE CORPORATION Company Profile and Main Business

Table 49. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 50. CELGENE CORPORATION Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 51. CELGENE CORPORATION Recent Developments

Table 52. Eureka Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Eureka Therapeutics Company Profile and Main Business

Table 54. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 55. Eureka Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 56. Eureka Therapeutics Recent Developments

Table 57. Avacta Life Sciences Company Information, Head Office, Market Area and Industry Position

Table 58. Avacta Life Sciences Company Profile and Main Business

Table 59. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 60. Avacta Life Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 61. Avacta Life Sciences Recent Developments

Table 62. Calyxt Company Information, Head Office, Market Area and Industry Position

Table 63. Calyxt Company Profile and Main Business

Table 64. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 65. Calyxt Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 66. Calyxt Recent Developments

Table 67. Celyad Oncology SA Company Information, Head Office, Market Area and Industry Position

Table 68. Celyad Oncology SA Company Profile and Main Business

Table 69. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 70. Celyad Oncology SA Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 71. Celyad Oncology SA Recent Developments

Table 72. Fortress Biotech Company Information, Head Office, Market Area and Industry Position

Table 73. Fortress Biotech Company Profile and Main Business

Table 74. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 75. Fortress Biotech Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 76. Fortress Biotech Recent Developments

Table 77. IMMUNE THERAPEUTICS Company Information, Head Office, Market Area and Industry Position

Table 78. IMMUNE THERAPEUTICS Company Profile and Main Business

Table 79. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 80. IMMUNE THERAPEUTICS Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 81. IMMUNE THERAPEUTICS Recent Developments

Table 82. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 83. Gilead Sciences Company Profile and Main Business

Table 84. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 85. Gilead Sciences Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 86. Gilead Sciences Recent Developments

Table 87. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 88. Novartis AG Company Profile and Main Business

Table 89. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 90. Novartis AG Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 91. Novartis AG Recent Developments

Table 92. Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 93. Alaunos Therapeutics Company Profile and Main Business

Table 94. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 95. Alaunos Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 96. Alaunos Therapeutics Recent Developments

Table 97. Poseida Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 98. Poseida Therapeutics Company Profile and Main Business

Table 99. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Models, Specifications and Application

Table 100. Poseida Therapeutics Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Gross Margin, 2019-2024

Table 101. Poseida Therapeutics Recent Developments

List of Figure

Figure 1. Chimeric Antigen Receptor (CAR)-T Cell Therapy Picture

Figure 2. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share of Global

Figure 5. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Chimeric Antigen Receptor (CAR)-T Cell Therapy Industry Chain

Figure 10. Abecma

Figure 11. Breyanzi

Figure 12. Kymriah

Figure 13. Tecartus

Figure 14. Yescarta

Figure 15. Others

Figure 16. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Figure 17. By Type, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 18. Hospital

Figure 19. Diagnostic Center

Figure 20. Other

Figure 21. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, US$ Million

Figure 22. By Application, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 23. By Region, Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2030

Figure 24. North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 25. By Country, North America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 26. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 27. By Country, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 28. Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 29. By Country/Region, Asia Pacific Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 30. South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 31. By Country, South America Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2019-2024

Figure 32. Middle East & Africa Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue & Forecasts, 2019-2030, US$ Million

Figure 33. U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 34. By Company, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 35. By Type, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 36. By Application, U.S. Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 37. Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 38. By Company, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 39. By Type, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 40. By Application, Europe Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 41. China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 42. By Company, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 43. By Type, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 44. By Application, China Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 45. Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 46. By Company, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 47. By Type, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 48. By Application, Japan Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 49. South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 50. By Company, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 51. By Type, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 52. By Application, South Korea Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 53. Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 54. By Company, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 55. By Type, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 56. By Application, Southeast Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 57. India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 58. By Company, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 59. By Type, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 60. By Application, India Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 61. Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue, 2019-2030, (US$ Million)

Figure 62. By Company, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Share, 2019-2024

Figure 63. By Type, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 64. By Application, Middle East & Asia Chimeric Antigen Receptor (CAR)-T Cell Therapy Revenue Market Share, 2022 VS 2029

Figure 65. Research Methodology

Figure 66. Breakdown of Primary Interviews

Figure 67. Bottom-up Approaches

Figure 68. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)